HIV-2 capsids distinguish high and low virus load patients in a West African community cohort

HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while n...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 28; no. S2; pp. B60 - B67
Main Authors Onyango, Clayton O., Leligdowicz, Aleksandra, Yokoyama, Masaru, Sato, Hironori, Song, Haihan, Nakayama, Emi E., Shioda, Tatsuo, de Silva, Thushan, Townend, John, Jaye, Assan, Whittle, Hilton, Rowland-Jones, Sarah, Cotten, Matthew
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 26.05.2010
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0264-410X
1873-2518
1873-2518
DOI10.1016/j.vaccine.2009.08.060

Cover

Abstract HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis.
AbstractList HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis.
Abstract HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis.
HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL.In vitroreplication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis.
HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis.
HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis.HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis.
HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5 alpha . These results provide new insights into HIV-2 pathogenesis.
Author Jaye, Assan
Townend, John
Rowland-Jones, Sarah
Nakayama, Emi E.
Leligdowicz, Aleksandra
Sato, Hironori
Onyango, Clayton O.
de Silva, Thushan
Yokoyama, Masaru
Shioda, Tatsuo
Song, Haihan
Cotten, Matthew
Whittle, Hilton
Author_xml – sequence: 1
  givenname: Clayton O.
  surname: Onyango
  fullname: Onyango, Clayton O.
  email: conyango@mrc.gm
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 2
  givenname: Aleksandra
  surname: Leligdowicz
  fullname: Leligdowicz, Aleksandra
  email: aleksandra.leligdowicz@mail.mcgill.ca
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 3
  givenname: Masaru
  surname: Yokoyama
  fullname: Yokoyama, Masaru
  email: yokoyama@nih.go.jp
  organization: Laboratory of Viral Genomics, Center for Pathogen Genomics, National Institute of Infectious Diseases, Tokyo 208-0011, Japan
– sequence: 4
  givenname: Hironori
  surname: Sato
  fullname: Sato, Hironori
  email: hirosato@nih.go.jp
  organization: Laboratory of Viral Genomics, Center for Pathogen Genomics, National Institute of Infectious Diseases, Tokyo 208-0011, Japan
– sequence: 5
  givenname: Haihan
  surname: Song
  fullname: Song, Haihan
  email: haihansong@hotmail.com
  organization: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
– sequence: 6
  givenname: Emi E.
  surname: Nakayama
  fullname: Nakayama, Emi E.
  email: emien@biken.osaka-u.ac.jp
  organization: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
– sequence: 7
  givenname: Tatsuo
  surname: Shioda
  fullname: Shioda, Tatsuo
  email: shioda@biken.osaka-u.ac.jp
  organization: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
– sequence: 8
  givenname: Thushan
  surname: de Silva
  fullname: de Silva, Thushan
  email: tdesilva@mrc.gm
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 9
  givenname: John
  surname: Townend
  fullname: Townend, John
  email: jtownend@mrc.gm
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 10
  givenname: Assan
  surname: Jaye
  fullname: Jaye, Assan
  email: ajaye@mrc.gm
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 11
  givenname: Hilton
  surname: Whittle
  fullname: Whittle, Hilton
  email: hwhittle@mrc.gm
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 12
  givenname: Sarah
  surname: Rowland-Jones
  fullname: Rowland-Jones, Sarah
  email: sarah.rowland-jones@ndm.ox.ac.uk
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
– sequence: 13
  givenname: Matthew
  surname: Cotten
  fullname: Cotten, Matthew
  email: mcotten@mrc.gm
  organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20510746$$D View this record in MEDLINE/PubMed
BookMark eNqNkl9rFDEUxYNU7Lb6EZSAD_Zlxpv_M0iVUtQWCj5Y1BcJaSbTzTqbWZOZLfvtzbhbhAWtT7kPv3Nyc06O0EHog0PoOYGSAJGvF-XaWOuDKylAXUJVgoRHaEYqxQoqSHWAZkAlLziBb4foKKUFAAhG6ifokIIgoLicoe8Xl18Kiq1ZJd8k3Pg0-HA7-jTHc387xyY0uOvv8NrHMeXJNHhlBu_CkLAP2OCvLg34rI3emoBtv1yOwQ-bPM37ODxFj1vTJfdsdx6j6w_vr88viqtPHy_Pz64KKwGGoqlaZWUFRnBghLaKG2nlTW04iEpwyRrKrRRUKiUI5QYsg8Yq0RqipLDsGL3a2q5i_3PMC-mlT9Z1nQmuH5NWjBGW5ZDJk3-SRACoGiivM_pyD130Ywz5GZrwWrGaM04z9WJHjTdL1-hV9EsTN_o-4Qy82QI29ilF12rrh5xgH4ZofKcJ6KlPvdC7PvXUp4ZKw-99xZ76_oKHdO-2OpdTX3sXdbK5NOsaH50ddNP7Bx3e7jnYzofccvfDbVz6k4VOVIP-PP216atBDYSyasrv9O8G_7HALx3z46c
CitedBy_id crossref_primary_10_2222_jsv_61_49
crossref_primary_10_1002_eji_201545451
crossref_primary_10_1097_COH_0b013e3283497155
crossref_primary_10_1016_j_micinf_2012_10_013
crossref_primary_10_3389_fimmu_2017_01616
crossref_primary_10_1093_ve_veac075
crossref_primary_10_1089_aid_2016_0229
crossref_primary_10_1016_j_isci_2019_100758
crossref_primary_10_1099_vir_0_058180_0
crossref_primary_10_1099_acmi_0_000087
crossref_primary_10_1371_journal_pone_0022779
crossref_primary_10_1097_QAD_0000000000001753
crossref_primary_10_1371_journal_ppat_1003352
crossref_primary_10_4103_ijmm_IJMM_20_109
crossref_primary_10_7554_eLife_39823
crossref_primary_10_1002_eji_200940295
crossref_primary_10_1002_rmv_1739
crossref_primary_10_3390_v15112236
crossref_primary_10_1186_s12977_014_0131_7
crossref_primary_10_1016_j_ebiom_2021_103258
crossref_primary_10_1093_infdis_jiu165
crossref_primary_10_1128_JVI_06126_11
crossref_primary_10_1186_1742_4690_7_72
crossref_primary_10_1371_journal_pone_0121199
crossref_primary_10_1111_cei_13280
crossref_primary_10_1586_eri_10_176
crossref_primary_10_1186_1742_4690_10_50
crossref_primary_10_1002_eji_202048931
crossref_primary_10_1128_JVI_00116_10
crossref_primary_10_1186_s12977_021_00577_x
Cites_doi 10.1038/ni0407-329
10.1126/science.283.5398.80
10.1016/S0969-2126(00)00507-4
10.1073/pnas.200286297
10.1126/science.1065659
10.1097/00002030-199407000-00016
10.1089/088922201750063197
10.1016/S0065-3233(03)66002-X
10.1093/molbev/msm092
10.1097/00002030-199308000-00015
10.1126/science.1140768
10.1128/JVI.68.11.7433-7447.1994
10.1128/JVI.79.10.5996-6004.2005
10.1089/08892220260387904
10.1007/BF01731581
10.1073/pnas.162299499
10.1038/nsb927
10.1126/science.1131528
10.1016/S0140-6736(85)92556-5
10.1126/science.1069660
10.1016/j.str.2005.09.010
10.1126/science.278.5339.849
10.1038/nature02915
10.1128/AAC.45.1.138-144.2001
10.1126/science.2425430
10.1172/JCI32380
10.1016/j.sbi.2008.02.001
10.1038/326662a0
10.1038/427791a
10.1097/QAD.0b013e3283021a8c
10.1097/00002030-200307040-00012
10.1073/pnas.0509996103
10.1038/nsmb.1497
10.1038/nature07746
10.1016/S0140-6736(89)92281-2
10.1128/JVI.00406-07
10.1097/00002030-200003100-00006
10.1128/JVI.72.10.7895-7899.1998
10.1128/JVI.68.8.4927-4936.1994
10.1038/nature02343
10.1126/science.1152905
10.1073/pnas.0936469100
10.1073/pnas.0404206101
10.1086/431197
10.1097/00042560-199709010-00005
10.1099/vir.0.18908-0
ContentType Journal Article
Copyright 2009 Elsevier Ltd
Elsevier Ltd
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Copyright Elsevier Limited May 26, 2010
Copyright_xml – notice: 2009 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright (c) 2009 Elsevier Ltd. All rights reserved.
– notice: Copyright Elsevier Limited May 26, 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1016/j.vaccine.2009.08.060
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Research Library Prep

MEDLINE
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage B67
ExternalDocumentID 3217332391
20510746
10_1016_j_vaccine_2009_08_060
S0264410X09012389
1_s2_0_S0264410X09012389
Genre Journal Article
GeographicLocations Guinea-Bissau
Guinea Bissau
GeographicLocations_xml – name: Guinea-Bissau
– name: Guinea Bissau
GrantInformation_xml – fundername: Medical Research Council
  grantid: MC_U190085856
– fundername: Medical Research Council
  grantid: G0801751
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFJKZ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HEJ
HLV
HMCUK
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAB
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNL
SPCBC
SSH
SSI
SSZ
SVS
T5K
UKHRP
UV1
WH7
WOW
WUQ
XPP
Z5R
ZGI
ZXP
~G-
3V.
AACTN
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
LCYCR
QYZTP
AAYXX
ACMHX
ADSLC
AGRNS
AGWPP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c600t-d8f7c680a540312f74a6c6b9a40585463d24c6526775124a0c30dc75fa1765c3
IEDL.DBID .~1
ISSN 0264-410X
1873-2518
IngestDate Fri Sep 05 08:53:41 EDT 2025
Thu Sep 04 23:21:56 EDT 2025
Wed Aug 13 09:10:30 EDT 2025
Sat May 31 02:09:25 EDT 2025
Thu Apr 24 23:00:52 EDT 2025
Tue Jul 01 03:37:47 EDT 2025
Fri Feb 23 02:28:40 EST 2024
Sun Feb 23 10:19:53 EST 2025
Tue Aug 26 17:02:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue S2
Keywords Capsid
TRIM5α
HIV-2
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-d8f7c680a540312f74a6c6b9a40585463d24c6526775124a0c30dc75fa1765c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 20510746
PQID 1497394342
PQPubID 105530
ParticipantIDs proquest_miscellaneous_733135260
proquest_miscellaneous_1500790249
proquest_journals_1497394342
pubmed_primary_20510746
crossref_citationtrail_10_1016_j_vaccine_2009_08_060
crossref_primary_10_1016_j_vaccine_2009_08_060
elsevier_sciencedirect_doi_10_1016_j_vaccine_2009_08_060
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X09012389
elsevier_clinicalkey_doi_10_1016_j_vaccine_2009_08_060
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-05-26
PublicationDateYYYYMMDD 2010-05-26
PublicationDate_xml – month: 05
  year: 2010
  text: 2010-05-26
  day: 26
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2010
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Monaco-Malbet, Berthet-Colominas, Novelli, Battai, Piga, Cheynet (bib27) 2000; 8
Shirakawa, Takaori-Kondo, Yokoyama, Izumi, Matsui, Io (bib26) 2008; 15
Poulsen, Kvinesdal, Aaby, Molbak, Frederiksen, Dias (bib5) 1989; 1
Towers, Bock, Martin, Takeuchi, Stoye, Danos (bib34) 2000; 97
Wilkins, Ricard, Todd, Whittle, Dias, Paulo Da Silva (bib50) 1993; 7
Stremlau, Owens, Perron, Kiessling, Autissier, Sodroski (bib32) 2004; 427
Stremlau (bib35) 2007; 318
Barin, M’Boup, Denis, Kanki, Allan, Lee (bib1) 1985; 2
Clavel, Guetard, Brun-Vezinet, Chamaret, Rey, Santos-Ferreira (bib2) 1986; 233
Tamura, Nei, Kumar (bib49) 2004; 101
Guyader, Emerman, Sonigo, Clavel, Montagnier, Alizon (bib31) 1987; 326
Brumme, Tao, Szeto, Brumme, Carlson, Chan (bib42) 2008; 22
Creighton (bib38) 1992
Berry, Jaffar, Schim van der Loeff, Ariyoshi, Harding, N’Gom (bib40) 2002; 18
Kinomoto, Yokoyama, Sato, Kojima, Kurata, Ikuta (bib24) 2005; 79
Klenerman, McMichael (bib45) 2007; 315
Norrgren, Marquina, Leitner, Aaby, Melbye, Poulsen (bib12) 1997; 16
Gao, Yue, Robertson, Hill, Hui, Biggar (bib9) 1994; 68
Leligdowicz, Yindom, Onyango, Sarge-Njie, Alabi, Cotten (bib14) 2007; 117
Gamble, Yoo, Vajdos, von Schwedler, Worthylake, Wang (bib19) 1997; 278
Baker, Sali (bib28) 2001; 294
Hall (bib22) 1999; 41
Alabi, Jaffar, Ariyoshi, Blanchard, Schim van der Loeff, Awasana (bib21) 2003; 17
Kimura (bib46) 1980; 16
Berry, Ariyoshi, Jaffar, Sabally, Corrah, Tedder (bib7) 1998; 1
Howard, Vajdos, Li, Sundquist, Hill (bib39) 2003; 10
Cowan, Hatziioannou, Cunningham, Muesing, Gottlinger, Bieniasz (bib36) 2002; 99
Moore, John, James, Christiansen, Witt, Mallal (bib41) 2002; 296
Rowland-Jones, Whittle (bib4) 2007; 8
Song, Nakayama, Yokoyama, Sato, Levy, Shioda (bib23) 2007; 81
Ponder, Case (bib29) 2003; 66
Tamura, Dudley, Nei, Kumar (bib47) 2007; 24
Lemey, Pybus, Wang, Saksena, Salemi, Vandamme (bib3) 2003; 100
Berry, Ariyoshi, Balfe, Tedder, Whittle (bib6) 2001; 17
Lee, Chu (bib30) 2001; 45
Ganser-Pornillos, Yeager, Sundquist (bib18) 2008; 18
Ganser, Li, Klishko, Finch, Sundquist (bib17) 1999; 283
Ricard, Wilkins, N’Gum, Hayes, Morgan, Da Silva (bib10) 1994; 8
Briggs, Grunewald, Glass, Forster, Krausslich, Fuller (bib16) 2006; 14
Mortuza, Haire, Stevens, Smerdon, Stoye, Taylor (bib15) 2004; 431
Ariyoshi, Jaffar, Alabi, Berry, Schim van der Loeff, Sabally (bib8) 2000; 14
Goff (bib33) 2004; 427
Bhattacharya, Daniels, Heckerman, Foley, Frahm, Kadie (bib43) 2007; 315
Saitou, Nei (bib48) 1987; 4
Kinomoto, Appiah-Opong, Brandful, Yokoyama, Nii-Trebi, Ugly-Kwame (bib25) 2005; 41
Grassly, Xiang, Ariyoshi, Aaby, Jensen, Schim van der Loeff (bib11) 1998; 72
Stremlau, Perron, Lee, Li, Song, Javanbakht (bib37) 2006; 103
Kawashima, Pfafferott, Frater, Matthews, Payne, Addo (bib44) 2009; 458
Mammano, Ohagen, Hoglund, Gottlinger (bib20) 1994; 68
Padua, Jenkins, Brown, Bootman, Paixao, Almond (bib13) 2003; 84
Monaco-Malbet (10.1016/j.vaccine.2009.08.060_bib27) 2000; 8
Stremlau (10.1016/j.vaccine.2009.08.060_bib37) 2006; 103
Rowland-Jones (10.1016/j.vaccine.2009.08.060_bib4) 2007; 8
Mammano (10.1016/j.vaccine.2009.08.060_bib20) 1994; 68
Moore (10.1016/j.vaccine.2009.08.060_bib41) 2002; 296
Tamura (10.1016/j.vaccine.2009.08.060_bib49) 2004; 101
Mortuza (10.1016/j.vaccine.2009.08.060_bib15) 2004; 431
Cowan (10.1016/j.vaccine.2009.08.060_bib36) 2002; 99
Ariyoshi (10.1016/j.vaccine.2009.08.060_bib8) 2000; 14
Kawashima (10.1016/j.vaccine.2009.08.060_bib44) 2009; 458
Shirakawa (10.1016/j.vaccine.2009.08.060_bib26) 2008; 15
Bhattacharya (10.1016/j.vaccine.2009.08.060_bib43) 2007; 315
Lee (10.1016/j.vaccine.2009.08.060_bib30) 2001; 45
Kimura (10.1016/j.vaccine.2009.08.060_bib46) 1980; 16
Gamble (10.1016/j.vaccine.2009.08.060_bib19) 1997; 278
Song (10.1016/j.vaccine.2009.08.060_bib23) 2007; 81
Padua (10.1016/j.vaccine.2009.08.060_bib13) 2003; 84
Leligdowicz (10.1016/j.vaccine.2009.08.060_bib14) 2007; 117
Ganser-Pornillos (10.1016/j.vaccine.2009.08.060_bib18) 2008; 18
Guyader (10.1016/j.vaccine.2009.08.060_bib31) 1987; 326
Kinomoto (10.1016/j.vaccine.2009.08.060_bib25) 2005; 41
Alabi (10.1016/j.vaccine.2009.08.060_bib21) 2003; 17
Towers (10.1016/j.vaccine.2009.08.060_bib34) 2000; 97
Berry (10.1016/j.vaccine.2009.08.060_bib7) 1998; 1
Wilkins (10.1016/j.vaccine.2009.08.060_bib50) 1993; 7
Klenerman (10.1016/j.vaccine.2009.08.060_bib45) 2007; 315
Ponder (10.1016/j.vaccine.2009.08.060_bib29) 2003; 66
Baker (10.1016/j.vaccine.2009.08.060_bib28) 2001; 294
Hall (10.1016/j.vaccine.2009.08.060_bib22) 1999; 41
Grassly (10.1016/j.vaccine.2009.08.060_bib11) 1998; 72
Tamura (10.1016/j.vaccine.2009.08.060_bib47) 2007; 24
Creighton (10.1016/j.vaccine.2009.08.060_bib38) 1992
Poulsen (10.1016/j.vaccine.2009.08.060_bib5) 1989; 1
Saitou (10.1016/j.vaccine.2009.08.060_bib48) 1987; 4
Lemey (10.1016/j.vaccine.2009.08.060_bib3) 2003; 100
Ganser (10.1016/j.vaccine.2009.08.060_bib17) 1999; 283
Stremlau (10.1016/j.vaccine.2009.08.060_bib32) 2004; 427
Gao (10.1016/j.vaccine.2009.08.060_bib9) 1994; 68
Briggs (10.1016/j.vaccine.2009.08.060_bib16) 2006; 14
Norrgren (10.1016/j.vaccine.2009.08.060_bib12) 1997; 16
Berry (10.1016/j.vaccine.2009.08.060_bib40) 2002; 18
Brumme (10.1016/j.vaccine.2009.08.060_bib42) 2008; 22
Ricard (10.1016/j.vaccine.2009.08.060_bib10) 1994; 8
Howard (10.1016/j.vaccine.2009.08.060_bib39) 2003; 10
Barin (10.1016/j.vaccine.2009.08.060_bib1) 1985; 2
Stremlau (10.1016/j.vaccine.2009.08.060_bib35) 2007; 318
Kinomoto (10.1016/j.vaccine.2009.08.060_bib24) 2005; 79
Goff (10.1016/j.vaccine.2009.08.060_bib33) 2004; 427
Clavel (10.1016/j.vaccine.2009.08.060_bib2) 1986; 233
Berry (10.1016/j.vaccine.2009.08.060_bib6) 2001; 17
References_xml – volume: 68
  start-page: 4927
  year: 1994
  end-page: 4936
  ident: bib20
  article-title: Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis
  publication-title: J Virol
– volume: 117
  start-page: 3067
  year: 2007
  end-page: 3074
  ident: bib14
  article-title: Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection
  publication-title: J Clin Invest
– volume: 427
  start-page: 791
  year: 2004
  end-page: 793
  ident: bib33
  article-title: HIV: replication trimmed back
  publication-title: Nature
– volume: 1
  start-page: 457
  year: 1998
  end-page: 468
  ident: bib7
  article-title: Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection
  publication-title: J Hum Virol
– volume: 97
  start-page: 12295
  year: 2000
  end-page: 12299
  ident: bib34
  article-title: A conserved mechanism of retrovirus restriction in mammals
  publication-title: Proc Natl Acad Sci USA
– volume: 100
  start-page: 6588
  year: 2003
  end-page: 6592
  ident: bib3
  article-title: Tracing the origin and history of the HIV-2 epidemic
  publication-title: Proc Natl Acad Sci USA
– volume: 18
  start-page: 203
  year: 2008
  end-page: 217
  ident: bib18
  article-title: The structural biology of HIV assembly
  publication-title: Curr Opin Struct Biol
– volume: 79
  start-page: 5996
  year: 2005
  end-page: 6004
  ident: bib24
  article-title: Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor
  publication-title: J Virol
– volume: 22
  start-page: 1277
  year: 2008
  end-page: 1286
  ident: bib42
  article-title: Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection
  publication-title: AIDS
– volume: 10
  start-page: 475
  year: 2003
  end-page: 481
  ident: bib39
  article-title: Structural insights into the catalytic mechanism of cyclophilin A
  publication-title: Nat Struct Biol
– volume: 15
  start-page: 1184
  year: 2008
  end-page: 1191
  ident: bib26
  article-title: Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif
  publication-title: Nat Struct Mol Biol
– volume: 18
  start-page: 1167
  year: 2002
  end-page: 1173
  ident: bib40
  article-title: Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers
  publication-title: AIDS Res Hum Retroviruses
– volume: 315
  start-page: 1583
  year: 2007
  end-page: 1586
  ident: bib43
  article-title: Founder effects in the assessment of HIV polymorphisms and HLA allele associations
  publication-title: Science
– volume: 16
  start-page: 111
  year: 1980
  end-page: 120
  ident: bib46
  article-title: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences
  publication-title: J Mol Evol
– volume: 296
  start-page: 1439
  year: 2002
  end-page: 1443
  ident: bib41
  article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
  publication-title: Science
– volume: 81
  start-page: 7280
  year: 2007
  end-page: 7285
  ident: bib23
  article-title: A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas
  publication-title: J Virol
– volume: 16
  start-page: 31
  year: 1997
  end-page: 38
  ident: bib12
  article-title: HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau
  publication-title: J Acquir Immune Defic Syndr Hum Retrovirol
– volume: 2
  start-page: 1387
  year: 1985
  end-page: 1389
  ident: bib1
  article-title: Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa
  publication-title: Lancet
– volume: 431
  start-page: 481
  year: 2004
  end-page: 485
  ident: bib15
  article-title: High-resolution structure of a retroviral capsid hexameric amino-terminal domain
  publication-title: Nature
– volume: 8
  start-page: 977
  year: 1994
  end-page: 982
  ident: bib10
  article-title: The effects of HIV-2 infection in a rural area of Guinea-Bissau
  publication-title: AIDS
– volume: 24
  start-page: 1596
  year: 2007
  end-page: 1599
  ident: bib47
  article-title: MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0
  publication-title: Mol Biol Evol
– volume: 41
  start-page: 95
  year: 1999
  end-page: 98
  ident: bib22
  article-title: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT
  publication-title: Nucleic Acids Symp Ser
– volume: 294
  start-page: 93
  year: 2001
  end-page: 96
  ident: bib28
  article-title: Protein structure prediction and structural genomics
  publication-title: Science
– year: 1992
  ident: bib38
  article-title: Proteins: Structures and Molecular Properties
– volume: 427
  start-page: 848
  year: 2004
  end-page: 853
  ident: bib32
  article-title: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old World monkeys
  publication-title: Nature
– volume: 278
  start-page: 849
  year: 1997
  end-page: 853
  ident: bib19
  article-title: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein
  publication-title: Science
– volume: 8
  start-page: 1069
  year: 2000
  end-page: 1077
  ident: bib27
  article-title: Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24
  publication-title: Structure
– volume: 283
  start-page: 80
  year: 1999
  end-page: 83
  ident: bib17
  article-title: Assembly and analysis of conical models for the HIV-1 core
  publication-title: Science
– volume: 68
  start-page: 7433
  year: 1994
  end-page: 7447
  ident: bib9
  article-title: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology
  publication-title: J Virol
– volume: 72
  start-page: 7895
  year: 1998
  end-page: 7899
  ident: bib11
  article-title: Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype
  publication-title: J Virol
– volume: 315
  start-page: 1505
  year: 2007
  end-page: 1507
  ident: bib45
  article-title: AIDS/HIV. Finding footprints among the trees
  publication-title: Science
– volume: 326
  start-page: 662
  year: 1987
  end-page: 669
  ident: bib31
  article-title: Genome organization and transactivation of the human immunodeficiency virus type 2
  publication-title: Nature
– volume: 99
  start-page: 11914
  year: 2002
  end-page: 11919
  ident: bib36
  article-title: Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
  publication-title: Proc Natl Acad Sci USA
– volume: 14
  start-page: 15
  year: 2006
  end-page: 20
  ident: bib16
  article-title: The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions
  publication-title: Structure
– volume: 8
  start-page: 329
  year: 2007
  end-page: 331
  ident: bib4
  article-title: Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
  publication-title: Nat Immunol
– volume: 458
  start-page: 641
  year: 2009
  end-page: 645
  ident: bib44
  article-title: Adaptation of HIV-1 to human leukocyte antigen class I
  publication-title: Nature
– volume: 1
  start-page: 827
  year: 1989
  end-page: 831
  ident: bib5
  article-title: Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa
  publication-title: Lancet
– volume: 66
  start-page: 27
  year: 2003
  end-page: 85
  ident: bib29
  article-title: Force fields for protein simulations
  publication-title: Adv Protein Chem
– volume: 101
  start-page: 11030
  year: 2004
  end-page: 11035
  ident: bib49
  article-title: Prospects for inferring very large phylogenies by using the neighbour-joining method
  publication-title: Proc Natl Acad Sci USA
– volume: 45
  start-page: 138
  year: 2001
  end-page: 144
  ident: bib30
  article-title: Molecular modelling approach to understanding the mode of action of
  publication-title: Antimicrob Agents Chemother
– volume: 103
  start-page: 5514
  year: 2006
  end-page: 5519
  ident: bib37
  article-title: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor
  publication-title: Proc Natl Acad Sci USA
– volume: 233
  start-page: 343
  year: 1986
  end-page: 346
  ident: bib2
  article-title: Isolation of a new human retrovirus from West African patients with AIDS
  publication-title: Science
– volume: 7
  start-page: 1119
  year: 1993
  end-page: 1122
  ident: bib50
  article-title: The epidemiology of HIV infection in a rural area of Guinea-Bissau
  publication-title: AIDS
– volume: 318
  start-page: 1565
  year: 2007
  end-page: 1566
  ident: bib35
  article-title: GE Prize-winning essay, Why old World monkeys are resistant to HIV-1
  publication-title: Science
– volume: 17
  start-page: 263
  year: 2001
  end-page: 267
  ident: bib6
  article-title: Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b
  publication-title: AIDS Res Hum Retroviruses
– volume: 84
  start-page: 1287
  year: 2003
  end-page: 1299
  ident: bib13
  article-title: Natural variation of the Nef gene in human immunodeficiency virus type 2 infections in Portugal
  publication-title: J Gen Virol
– volume: 17
  start-page: 1513
  year: 2003
  end-page: 1520
  ident: bib21
  article-title: Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients
  publication-title: AIDS
– volume: 14
  start-page: 339
  year: 2000
  end-page: 344
  ident: bib8
  article-title: Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa
  publication-title: AIDS
– volume: 41
  start-page: 243
  year: 2005
  end-page: 251
  ident: bib25
  article-title: HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors
  publication-title: Clin Infect Dis
– volume: 4
  start-page: 406
  year: 1987
  end-page: 425
  ident: bib48
  article-title: The neighbor-joining method: a new method for reconstructing phylogenetic trees
  publication-title: Mol Biol Evol
– volume: 8
  start-page: 329
  issue: 4
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib4
  article-title: Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
  publication-title: Nat Immunol
  doi: 10.1038/ni0407-329
– volume: 283
  start-page: 80
  issue: 5398
  year: 1999
  ident: 10.1016/j.vaccine.2009.08.060_bib17
  article-title: Assembly and analysis of conical models for the HIV-1 core
  publication-title: Science
  doi: 10.1126/science.283.5398.80
– volume: 8
  start-page: 1069
  issue: 10
  year: 2000
  ident: 10.1016/j.vaccine.2009.08.060_bib27
  article-title: Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24
  publication-title: Structure
  doi: 10.1016/S0969-2126(00)00507-4
– volume: 1
  start-page: 457
  issue: 7
  year: 1998
  ident: 10.1016/j.vaccine.2009.08.060_bib7
  article-title: Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection
  publication-title: J Hum Virol
– volume: 97
  start-page: 12295
  issue: 22
  year: 2000
  ident: 10.1016/j.vaccine.2009.08.060_bib34
  article-title: A conserved mechanism of retrovirus restriction in mammals
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.200286297
– year: 1992
  ident: 10.1016/j.vaccine.2009.08.060_bib38
– volume: 294
  start-page: 93
  issue: 5540
  year: 2001
  ident: 10.1016/j.vaccine.2009.08.060_bib28
  article-title: Protein structure prediction and structural genomics
  publication-title: Science
  doi: 10.1126/science.1065659
– volume: 41
  start-page: 95
  year: 1999
  ident: 10.1016/j.vaccine.2009.08.060_bib22
  article-title: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT
  publication-title: Nucleic Acids Symp Ser
– volume: 8
  start-page: 977
  issue: 7
  year: 1994
  ident: 10.1016/j.vaccine.2009.08.060_bib10
  article-title: The effects of HIV-2 infection in a rural area of Guinea-Bissau
  publication-title: AIDS
  doi: 10.1097/00002030-199407000-00016
– volume: 17
  start-page: 263
  issue: 3
  year: 2001
  ident: 10.1016/j.vaccine.2009.08.060_bib6
  article-title: Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/088922201750063197
– volume: 66
  start-page: 27
  year: 2003
  ident: 10.1016/j.vaccine.2009.08.060_bib29
  article-title: Force fields for protein simulations
  publication-title: Adv Protein Chem
  doi: 10.1016/S0065-3233(03)66002-X
– volume: 24
  start-page: 1596
  issue: 8
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib47
  article-title: MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0
  publication-title: Mol Biol Evol
  doi: 10.1093/molbev/msm092
– volume: 7
  start-page: 1119
  issue: 8
  year: 1993
  ident: 10.1016/j.vaccine.2009.08.060_bib50
  article-title: The epidemiology of HIV infection in a rural area of Guinea-Bissau
  publication-title: AIDS
  doi: 10.1097/00002030-199308000-00015
– volume: 315
  start-page: 1505
  issue: 5818
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib45
  article-title: AIDS/HIV. Finding footprints among the trees
  publication-title: Science
  doi: 10.1126/science.1140768
– volume: 68
  start-page: 7433
  issue: 11
  year: 1994
  ident: 10.1016/j.vaccine.2009.08.060_bib9
  article-title: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology
  publication-title: J Virol
  doi: 10.1128/JVI.68.11.7433-7447.1994
– volume: 79
  start-page: 5996
  issue: 10
  year: 2005
  ident: 10.1016/j.vaccine.2009.08.060_bib24
  article-title: Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor
  publication-title: J Virol
  doi: 10.1128/JVI.79.10.5996-6004.2005
– volume: 18
  start-page: 1167
  issue: 16
  year: 2002
  ident: 10.1016/j.vaccine.2009.08.060_bib40
  article-title: Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/08892220260387904
– volume: 16
  start-page: 111
  issue: 2
  year: 1980
  ident: 10.1016/j.vaccine.2009.08.060_bib46
  article-title: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences
  publication-title: J Mol Evol
  doi: 10.1007/BF01731581
– volume: 99
  start-page: 11914
  issue: 18
  year: 2002
  ident: 10.1016/j.vaccine.2009.08.060_bib36
  article-title: Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.162299499
– volume: 10
  start-page: 475
  issue: 6
  year: 2003
  ident: 10.1016/j.vaccine.2009.08.060_bib39
  article-title: Structural insights into the catalytic mechanism of cyclophilin A
  publication-title: Nat Struct Biol
  doi: 10.1038/nsb927
– volume: 315
  start-page: 1583
  issue: 5818
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib43
  article-title: Founder effects in the assessment of HIV polymorphisms and HLA allele associations
  publication-title: Science
  doi: 10.1126/science.1131528
– volume: 2
  start-page: 1387
  issue: 8469–70
  year: 1985
  ident: 10.1016/j.vaccine.2009.08.060_bib1
  article-title: Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa
  publication-title: Lancet
  doi: 10.1016/S0140-6736(85)92556-5
– volume: 296
  start-page: 1439
  issue: 5572
  year: 2002
  ident: 10.1016/j.vaccine.2009.08.060_bib41
  article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
  publication-title: Science
  doi: 10.1126/science.1069660
– volume: 14
  start-page: 15
  issue: 1
  year: 2006
  ident: 10.1016/j.vaccine.2009.08.060_bib16
  article-title: The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions
  publication-title: Structure
  doi: 10.1016/j.str.2005.09.010
– volume: 278
  start-page: 849
  issue: 5339
  year: 1997
  ident: 10.1016/j.vaccine.2009.08.060_bib19
  article-title: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein
  publication-title: Science
  doi: 10.1126/science.278.5339.849
– volume: 431
  start-page: 481
  issue: 7007
  year: 2004
  ident: 10.1016/j.vaccine.2009.08.060_bib15
  article-title: High-resolution structure of a retroviral capsid hexameric amino-terminal domain
  publication-title: Nature
  doi: 10.1038/nature02915
– volume: 45
  start-page: 138
  issue: 1
  year: 2001
  ident: 10.1016/j.vaccine.2009.08.060_bib30
  article-title: Molecular modelling approach to understanding the mode of action of l-nucleosides as antiviral agents
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.45.1.138-144.2001
– volume: 233
  start-page: 343
  issue: 4761
  year: 1986
  ident: 10.1016/j.vaccine.2009.08.060_bib2
  article-title: Isolation of a new human retrovirus from West African patients with AIDS
  publication-title: Science
  doi: 10.1126/science.2425430
– volume: 117
  start-page: 3067
  issue: 10
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib14
  article-title: Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection
  publication-title: J Clin Invest
  doi: 10.1172/JCI32380
– volume: 18
  start-page: 203
  issue: 2
  year: 2008
  ident: 10.1016/j.vaccine.2009.08.060_bib18
  article-title: The structural biology of HIV assembly
  publication-title: Curr Opin Struct Biol
  doi: 10.1016/j.sbi.2008.02.001
– volume: 326
  start-page: 662
  issue: 6114
  year: 1987
  ident: 10.1016/j.vaccine.2009.08.060_bib31
  article-title: Genome organization and transactivation of the human immunodeficiency virus type 2
  publication-title: Nature
  doi: 10.1038/326662a0
– volume: 427
  start-page: 791
  issue: 6977
  year: 2004
  ident: 10.1016/j.vaccine.2009.08.060_bib33
  article-title: HIV: replication trimmed back
  publication-title: Nature
  doi: 10.1038/427791a
– volume: 22
  start-page: 1277
  issue: 11
  year: 2008
  ident: 10.1016/j.vaccine.2009.08.060_bib42
  article-title: Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3283021a8c
– volume: 17
  start-page: 1513
  issue: 10
  year: 2003
  ident: 10.1016/j.vaccine.2009.08.060_bib21
  article-title: Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients
  publication-title: AIDS
  doi: 10.1097/00002030-200307040-00012
– volume: 103
  start-page: 5514
  issue: 14
  year: 2006
  ident: 10.1016/j.vaccine.2009.08.060_bib37
  article-title: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0509996103
– volume: 15
  start-page: 1184
  issue: 11
  year: 2008
  ident: 10.1016/j.vaccine.2009.08.060_bib26
  article-title: Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.1497
– volume: 458
  start-page: 641
  issue: 7238
  year: 2009
  ident: 10.1016/j.vaccine.2009.08.060_bib44
  article-title: Adaptation of HIV-1 to human leukocyte antigen class I
  publication-title: Nature
  doi: 10.1038/nature07746
– volume: 1
  start-page: 827
  issue: 8642
  year: 1989
  ident: 10.1016/j.vaccine.2009.08.060_bib5
  article-title: Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa
  publication-title: Lancet
  doi: 10.1016/S0140-6736(89)92281-2
– volume: 81
  start-page: 7280
  issue: 13
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib23
  article-title: A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas
  publication-title: J Virol
  doi: 10.1128/JVI.00406-07
– volume: 14
  start-page: 339
  issue: 4
  year: 2000
  ident: 10.1016/j.vaccine.2009.08.060_bib8
  article-title: Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa
  publication-title: AIDS
  doi: 10.1097/00002030-200003100-00006
– volume: 72
  start-page: 7895
  issue: 10
  year: 1998
  ident: 10.1016/j.vaccine.2009.08.060_bib11
  article-title: Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype
  publication-title: J Virol
  doi: 10.1128/JVI.72.10.7895-7899.1998
– volume: 68
  start-page: 4927
  issue: 8
  year: 1994
  ident: 10.1016/j.vaccine.2009.08.060_bib20
  article-title: Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis
  publication-title: J Virol
  doi: 10.1128/JVI.68.8.4927-4936.1994
– volume: 427
  start-page: 848
  issue: 6977
  year: 2004
  ident: 10.1016/j.vaccine.2009.08.060_bib32
  article-title: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old World monkeys
  publication-title: Nature
  doi: 10.1038/nature02343
– volume: 318
  start-page: 1565
  issue: 5856
  year: 2007
  ident: 10.1016/j.vaccine.2009.08.060_bib35
  article-title: GE Prize-winning essay, Why old World monkeys are resistant to HIV-1
  publication-title: Science
  doi: 10.1126/science.1152905
– volume: 100
  start-page: 6588
  issue: 11
  year: 2003
  ident: 10.1016/j.vaccine.2009.08.060_bib3
  article-title: Tracing the origin and history of the HIV-2 epidemic
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0936469100
– volume: 101
  start-page: 11030
  issue: 30
  year: 2004
  ident: 10.1016/j.vaccine.2009.08.060_bib49
  article-title: Prospects for inferring very large phylogenies by using the neighbour-joining method
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0404206101
– volume: 41
  start-page: 243
  issue: 2
  year: 2005
  ident: 10.1016/j.vaccine.2009.08.060_bib25
  article-title: HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors
  publication-title: Clin Infect Dis
  doi: 10.1086/431197
– volume: 16
  start-page: 31
  issue: 1
  year: 1997
  ident: 10.1016/j.vaccine.2009.08.060_bib12
  article-title: HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau
  publication-title: J Acquir Immune Defic Syndr Hum Retrovirol
  doi: 10.1097/00042560-199709010-00005
– volume: 4
  start-page: 406
  issue: 4
  year: 1987
  ident: 10.1016/j.vaccine.2009.08.060_bib48
  article-title: The neighbor-joining method: a new method for reconstructing phylogenetic trees
  publication-title: Mol Biol Evol
– volume: 84
  start-page: 1287
  issue: Pt 5
  year: 2003
  ident: 10.1016/j.vaccine.2009.08.060_bib13
  article-title: Natural variation of the Nef gene in human immunodeficiency virus type 2 infections in Portugal
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.18908-0
SSID ssj0005319
Score 2.1613548
Snippet HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An...
Abstract HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL)....
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage B60
SubjectTerms Acquired immune deficiency syndrome
AIDS
Allergy and Immunology
Antiviral Restriction Factors
Capsid
Capsid - virology
Carrier Proteins - metabolism
Cohort Studies
Deoxyribonucleic acid
DNA
gag Gene Products, Human Immunodeficiency Virus - metabolism
Guinea-Bissau
HIV
HIV Infections - virology
HIV-2
HIV-2 - genetics
HIV-2 - pathogenicity
HIV-2 - physiology
Human immunodeficiency virus
Human immunodeficiency virus 1
Human immunodeficiency virus 2
Humans
Infections
Models, Molecular
Patients
Phylogenetics
Phylogeny
Plasma
Polymerase chain reaction
Polymorphism, Genetic
RNA, Viral - genetics
Sequence Analysis, Protein
Studies
TRIM5α
Tripartite Motif Proteins
Ubiquitin-Protein Ligases
Viral Load
Virus Replication
Viruses
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgCMTLBOVXxkCHhPa0bG7i2MkTQoipIA1Nokx5QZZjp9BpSkuTDvW_5y5xmhfKeIsUnxzl7PNn--77GHtbFs6ILI1DlyYiFE6WobECNysiMoVIHLqcCpzPv8jJN_E5T3J_4Fb7tMo-JraB2i0snZGfIpJXMZGZRe-Wv0JSjaLbVS-hcZfda6nLcDyrXA0pHnEr7IHbDPyMMc-HCp7Tq5MbY-nq2lNWEosn37U27cKe7Rp09ojte_AI7ztvP2Z3ymrE7ndykpsRe3DuL8pH7Oiio6TeHMN0qLCqj-EILgayarQZXVI-TFuUC735E_Z98ukyjMCaJQ7WGhwFgurHel7_BOI3BlM5uF78hpv5al3jk3HgCVprmFdggARroNMgqsB2RSjNBkiOd9U8ZdOzj9MPk9ALMYQW8VCDfpwpK1NuEN7F42imhJFWFplBtJcSn76LhJVJJJVC_CAMtzF3ViUzM1YysfEztlctqvIFA1NY3CDGssA2YuZmWYlNcZPMx6VBKFgETPQe0NaTlJNWxrXus9GutHccCWhmmjQ0JQ_YydZs2bF03GYge_fqvgQVg6bGdeQ2Q_U3w7L2U7_WY11HmuuvvIWaPOcZwdY0C1i6tfTopkMt_9PpYT8C9dDPdkIE7M32NQYHuvExVblYY5sEIWBGrJABgx1tSLSTRBKwl-fd4N7-wogithLy4N_9v2QP-5yKSB6yvWa1Ll8hVGuK1-18_ANKyDs-
  priority: 102
  providerName: ProQuest
Title HIV-2 capsids distinguish high and low virus load patients in a West African community cohort
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X09012389
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X09012389
https://dx.doi.org/10.1016/j.vaccine.2009.08.060
https://www.ncbi.nlm.nih.gov/pubmed/20510746
https://www.proquest.com/docview/1497394342
https://www.proquest.com/docview/1500790249
https://www.proquest.com/docview/733135260
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELamIRAvCMqvbAMZCe1pad3EsZPHUW3qQKsqKFNfkOXYCXSa0qpJh_rC385d4rQgqIZ4SaLkTo5yl_NZvvs-Qt5mqdU8iUPfxhH3uRWZrw2HxQoPdMojCybHBufLkRh-5u-n0XSPDNpeGCyrdLG_iel1tHZ3eu5r9hazWe8Tq-dyNmUJ5gUxNvFxLtHXuz9-KfMIa3IPFPZRetvF07vu3mqD29cOthKRPNmu-WlX_lnPQ-ePySOXQNLT5h2fkL2s6JD7DaXkukMeXLrN8g45Hjew1OsTOtl2WZUn9JiOt4DVoNO5wpqYujGXtupPyZfhxZUfUKMX4LAltRgMiq-rWfmNIsYx1YWlN_Pv9Ha2XJVwpS11IK0lnRVUUyStoQ0PUUFN04hSrSlS8i6rZ2RyfjYZDH1HxuAbyIkqsGUujYiZhhQv7Ae55FoYkSYaMr4YMfVtwI2IAiEl5BBcMxMya2SU674UkQmfk_1iXmQvCdWpgUViKFKQ4bnNkwxEYaHM-pmGdDD1CG8toIwDKke-jBvVVqRdK2c4JNFMFPJoCuaR7kZt0SB13KUgWvOqtg0VAqeCueQuRfk3xax0v3-p-qoMFFN_uKhH4o3mb17-L4MetR6otuPwRIaI8Bd45M3mMQQI3PXRRTZfgUwEaWCCyJAeoTtkkLgTiRJglBeNc28-YYBRW3Jx8P-vfkgetjUXgTgi-9Vylb2CVK5KX9f_KhzlVMIxHsD1vdOLD8MRnN-djcYffwJJmkpD
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VVDwuCMIrUMBI0FO3dbxe7-4BIR6tEtpEEYQqF2R57Q2kqjYhm7TKj-I_MpPdTS6EcuktUjxxkrFnvll7vg_gdZo4I-PI91wUSE86lXrGSixWpDCJDBy6nBqcO13V-iY_D4LBFvyuemHoWmUVE5eB2o0tPSM_QCQf-kRmJt5NfnmkGkWnq5WERrEsjtPFJZZs-dv2J_TvGyGODvsfW16pKuBZTO4z_FLD0KqIG8QqflMMQ2mUVUlsELpERA7vhLQqECoMMRlKw63PnQ2DoWmGKrA-fuwN2JbU0FqD7Q-H3d6X9Z0Sf6kkgnUN_u4mH6xbhg7O9i-MpbPykiOTaEP5pmS4Cewuk97RPbhbolX2vlhe92Erzepws9CvXNThVqc8ma_Dbq_gwF7ssf66pSvfY7ust2bHRpv6KV3AWXYBs8r8AXxvtU89wayZ4O7ImaPIk_2Yj_KfjAiVmckcOx9fsovRdJ7jK-NYyQibs1HGDCOFHFaIHmXMFl0vswUj_d_p7CH0r8NHj6CWjbP0CTCTWKxIfZXgGDl0wzjFoViV82ZqEHsmDZCVB7QtWdFJnONcV9ffznTpOFLsjDWJdiregP2V2aSgBbnKQFXu1VXPK0ZpjYnrKsPwb4ZpXsaaXDd1LjTXX_kS2_IBjwknR3EDopVlCacKmPQ_k-5UK1Cv51ntwAa8Wr2N0YiOmEyWjuc4JkDMGRMNZQPYhjGkEkqqDDjL42Jxr_5CQSkilOrpv-d_Cbdb_c6JPml3j5_BnepCh1A7UJtN5-lzxImz5EW5Oxnoa44HfwBex3aR
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NbxMxEB2VIiouCMJXoICRoKdu4-x67d0DQogSJZRWkShVLsjy2ruQqtqEbNIqP41_x8x-JBdCufQWKZ442rFnntcz7wG8SRNnRBwFnotC4QknU89YgYcV4ZtEhA5dTg3Oxyey_018HoWjLfjd9MJQWWUTE8tA7SaW3pF3EMmrgMjM_E5Wl0UMD3vvp788UpCim9ZGTqNaIkfp8gqPb8W7wSH6-q3v9z6dfux7tcKAZzHRz_EPZsrKiBvELUHXz5Qw0sokNghjIiKKd76wMvSlUpgYheE24M6qMDNdJUMb4M_egtsqQFCFW0mN1Lq6JCg1RfCEg0-gy0fr5qHO-cGlsXRrXrNlEoEo35QWN8HeMv317sO9GreyD9VCewBbad6CO5WS5bIFO8f1HX0L9oYVG_Zyn52um7uKfbbHhmuebLRpnVEpTtkPzBrzh_C9PzjzfGbNFPdJwRzFoPzHYlz8ZEStzEzu2MXkil2OZ4sCPxnHam7Ygo1zZhhp5bBK_ihntup_mS8ZKQHP5o_g9CY89Bi280mePgVmEotn00AmOEZkLotTHIrnc95NDaLQpA2i8YC2NT86yXRc6KYQ7lzXjiPtzliTfKfkbThYmU0rgpDrDGTjXt10v2K81pjCrjNUfzNMizrqFLqrC19z_ZWXKJePeEyIOYrbEK0sa2BVAab_mXS3WYF6Pc9qL7bh9eprjEt02WTydLLAMSGiz5gIKdvANowhvVDSZ8BZnlSLe_UIfUoWSshn_57_FexgFNBfBidHz-FuU9nhy13Yns8W6QsEjPPkZbk1GegbDgV_AJ0ieVg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIV-2+capsids+distinguish+high+and+low+virus+load+patients+in+a+West+African+community+cohort&rft.jtitle=Vaccine&rft.au=Onyango%2C+Clayton+O.&rft.au=Leligdowicz%2C+Aleksandra&rft.au=Yokoyama%2C+Masaru&rft.au=Sato%2C+Hironori&rft.date=2010-05-26&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.volume=28&rft.spage=B60&rft.epage=B67&rft_id=info:doi/10.1016%2Fj.vaccine.2009.08.060&rft.externalDocID=S0264410X09012389
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X10X00184%2Fcov150h.gif